Healthcare technology firm Cue Health has selected Cardinal Health to distribute its molecular Covid-19 tests.

The company’s professional use and over-the-counter Covid-19 molecular tests will now be available through the Cardinal Health distribution network for pharmacies, hospitals and non-clinical consumer markets.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The tests will be available for health professionals and other qualified point-of-care test users and include the Cue COVID-19 Test for CLIA Certified Healthcare Providers and Laboratories (Professional), the Cue Health Monitoring System, and Cue COVID-19 Test Positive Control Swabs and Test Negative Control Swabs.

Cue Health stated that the collaboration with Cardinal Health will help speed up the reach of the company’s nucleic acid amplification test (NAAT) into non-traditional and traditional healthcare settings.

Cue Health co-founder and CEO Ayub Khattak said: “Customers across the country trust Cardinal Health to deliver high-quality laboratory products, and Cue shares a goal with them of placing diagnostic information at the centre of care.

See Also:

 “We look forward to making Cue’s highly accurate, fast and easy-to-use testing and access to real-time health information more widely available through our collaboration with Cardinal Health.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company noted that the Cue COVID-19 Test for Home and Over The Counter (OTC) Use (OTC/Home) is also available through the Cardinal Health distribution network.

It is claimed to be the first molecular diagnostic test of any kind that is available for use at home or in other non-clinical settings without a prescription.

Through the Cue Health App, the rechargeable Cue Health Monitoring System (Reader) securely sends results to the mobile smart device of the user in 20 minutes.

Furthermore, the company provides in-app supervised testing through its Cue+ membership programme and 24/7 on-demand virtual care from board-certified physicians.